Furthermore, some studies revealed that the MMP-1 promoter polymorphism (−1607 1G/2G) has an association with prognosis in tongue cancer [36], breast cancer [37] and colorectal cancer [38]. This evidence concerns the gene MMP1 and colorectal cancer.